Tom Gardner, CEO and Founder of Omeza, a skin innovations and life sciences company specializing in skin care and wound management products from the sea joins eHealth Radio and the Health News and Skin Care Channels.
Listen to interview with host Eric Michaels and guest Tom Gardner discuss the following:
- What is value-based health care?
- Can you give me an example?
- Why the shift now?
- What is Omeza doing to support the initiative of value-based health care?
- Are insurance companies supporting this shift to value-based care?
- What’s your forecast for where value-based care is headed in the future?
Tom Gardner is Founder and CEO of Omeza, LLC, as well as managing member of KeyView, LLC. KeyView works with investors, owners and CEO’s of startup to early-stage health care companies. Tom is also founder and managing member of KeyView Labs (cognitive health dietary supplements), former chairman of IntegriChain (informed software applications for the pharmaceutical industry sold to Accel-KKR), and former chairman of MMIT (managed market insights and technology for the pharmaceuticals industry). He is an investor in and board chairman of Florida Mobile Physicians (medical house calls) and co-founder and co-manager of BRIDGE Angel Investors, LLC.
Prior to KeyView, Tom was CEO of several public and private companies including Nucryst Pharmaceuticals (sold to Smith & Nephew), Songbird Hearing (sold controlling interest to Procter & Gamble), Datamonitor (IPO on London Stock Exchange), Base Ten Systems (assets sold to Smiths Aerospace and ABB Group), and Access Health (sold to HBOC then became part of McKesson Health Solutions). Earlier, Tom held marketing and general management positions at Procter & Gamble and Johnson & Johnson. He earned a B.A. in Economics and Mathematics from the University of St. Thomas (Minnesota) and has been a guest lecturer on marketing channels at Northwestern University’s Kellogg Graduate School of Management.